Serum Drug Concentrations Predictive of Pulmonary Tuberculosis OutcomesPASIPANODYA, Jotam G; MCLLLERON, Helen; BURGER, André et al.The Journal of infectious diseases. 2013, Vol 208, Num 9, pp 1464-1473, issn 0022-1899, 10 p.Article

Population pharmacokinetics of nevirapine in combination with rifampicin-based short course chemotherapy in HIV-and tuberculosis-infected South African patientsELSHERBINY, Doaa; COHEN, Karen; JANSSON, Britt et al.European journal of clinical pharmacology. 2009, Vol 65, Num 1, pp 71-80, issn 0031-6970, 10 p.Article

Determinants of rifampin, isoniazid, pyrazinamide, and ethambutol pharmacokinetics in a cohort of tuberculosis patientsMCLLLERON, Helen; WASH, Peter; BURGER, André et al.Antimicrobial agents and chemotherapy. 2006, Vol 50, Num 4, pp 1170-1177, issn 0066-4804, 8 p.Article

Tuberculosis 5 Global tuberculosis drug development pipeline: the need and the realityZHENKUN MA; LIENHARDT, Christian; MCLLLERON, Helen et al.Lancet (British edition). 2010, Vol 375, Num 9731, pp 2100-2109, issn 0140-6736, 10 p.Article

Combined therapy for tuberculosis and HIV-1 : the challenge for drug discoveryPEPPER, Dominique J; MEINTJES, Graeme A; MCLLLERON, Helen et al.Drug discovery today. 2007, Vol 12, Num 21-22, pp 980-989, issn 1359-6446, 10 p.Article

A Time-to-Event Pharmacodynamic Model Describing Treatment Response in Patients with Pulmonary Tuberculosis Using Days to Positivity in Automated Liquid Mycobacterial CultureCHIGUTSA, Emmanuel; PATEL, Kashyap; DENTI, Paolo et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 2, pp 789-795, issn 0066-4804, 7 p.Article

Population Pharmacokinetics and Pharmacodynamics of Ofloxacin in South African Patients with Multidrug-Resistant TuberculosisCHIGUTSA, Emmanuel; MEREDITH, Sandra; WIESNER, Lubbe et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 7, pp 3857-3863, issn 0066-4804, 7 p.Article

Population pharmacokinetics of lopinavir and ritonavir in combination with rifampicin-based antitubercular treatment in HIV-infected childrenCHAO ZHANG; MCLLLERON, Helen; YUAN REN et al.Antiviral therapy (London). 2012, Vol 17, Num 1, pp 25-33, issn 1359-6535, 9 p.Article

Reduced Antituberculosis Drug Concentrations in HIV-Infected Patients Who Are Men or Have Low Weight: Implications for International Dosing GuidelinesMCLLLERON, Helen; RUSTOMJEE, Roxana; VAHEDI, Mahnaz et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 6, pp 3232-3238, issn 0066-4804, 7 p.Article

Pharmacokinetics of nevirapine in HIV-infected children under 3 years on rifampicin-based antituberculosis treatmentMIRJAM OUDIJK, J; MCLLLERON, Helen; MULENGA, Veronica et al.AIDS (London). 2012, Vol 26, Num 12, pp 1523-1528, issn 0269-9370, 6 p.Article

Isoniazid Plasma Concentrations in a Cohort of South African Children with Tuberculosis: Implications for International Pediatric Dosing GuidelinesMCLLLERON, Helen; WILLEMSE, Marianne; WERELY, Cedric J et al.Clinical infectious diseases. 2009, Vol 48, Num 11, pp 1547-1553, issn 1058-4838, 7 p.Article

The early bactericidal activities of rifampin and rifapentine in pulmonary tuberculosisSIRGEL, Frik A; BERNARD FOURIE, P; DONALD, Peter R et al.American journal of respiratory and critical care medicine. 2005, Vol 172, Num 1, pp 128-135, issn 1073-449X, 8 p.Article

Model-based approach to dose optimization of lopinavir/ritonavir when co-administered with rifampicinCHAO ZHANG; DENTI, Paolo; DECLOEDT, Eric et al.British journal of clinical pharmacology. 2012, Vol 73, Num 5, pp 758-767, issn 0306-5251, 10 p.Article

Effect of rifampicin-based antitubercular therapy and the cytochrome P450 2B6 516G>T polymorphism on efavirenz concentrations in adults in South AfricaCOHEN, Karen; GRANT, Alison; DANDARA, Collet et al.Antiviral therapy (London). 2009, Vol 14, Num 5, pp 687-695, issn 1359-6535, 9 p.Article

Effect of Rifampicin on Efavirenz Pharmacokinetics in HIV-lnfected Children With TuberculosisYUAN REN; NUTTALL, James J. C; ELEY, Brian S et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 50, Num 5, pp 439-443, issn 1525-4135, 5 p.Article

Effect of Rifampicin on Lopinavir Pharmacokinetics in HIV-Infected Children With TuberculosisYUAN REN; NUTTALL, James J. C; EGBERS, Claire et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 47, Num 5, pp 566-569, issn 1525-4135, 4 p.Article

High prevalence of subtherapeutic plasma concentrations of efavirenz in childrenYUAN REN; NUTTALL, James J. C; EGBERS, Claire et al.Journal of acquired immune deficiency syndromes (1999). 2007, Vol 45, Num 2, pp 133-136, issn 1525-4135, 4 p.Article

Moxifloxacin Population Pharmacokinetics in Patients with Pulmonary Tuberculosis and the Effect of Intermittent High-Dose RifapentineZVADA, Simbarashe P; DENTI, Paolo; HARRISON, Thomas et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 8, pp 4471-4473, issn 0066-4804, 3 p.Article

High-Dose Rifapentine with Moxifloxacin for Pulmonary TuberculosisJINDANI, Amina; HARRISON, Thomas S; MUNGOFA, Stanley et al.The New England journal of medicine. 2014, Vol 371, Num 17, pp 1599-1608, issn 0028-4793, 10 p.Article